HW
CDLX icon

Hancock Whitney’s Cardlytics CDLX Stock Holding History

Hancock Whitney’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$1.27M – 690
2021
Q2 		$1.27M Sell
1,000
-300
-23% -$339K 0.04% 365
2021
Q1 		$1.43M Sell
1,300
-613
-32% -$809K 0.05% 348
2020
Q4 		$2.73M Sell
1,913
-1,313
-41% -$1.4M 0.09% 203
2020
Q3 		$2.28M Sell
3,226
-485
-13% -$353K 0.08% 198
2020
Q2 		$2.6M Sell
3,711
-1,568
-30% -$905K 0.1% 179
2020
Q1 		$1.85M Sell
5,279
-4,009
-43% -$2.84M 0.07% 253
2019
Q4 		$5.84M Sell
9,288
-1,921
-17% -$939K 0.19% 143
2019
Q3 		$3.76M Buy
+11,209
New +$3.59M 0.12% 207

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Hancock Whitney's CDLX Position: Q3 2021 in Review

Hancock Whitney sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 1,000 shares — an estimated $1.27M sold.

Hancock Whitney first reported a position in CDLX in Q3 2019 and held it in 8 quarters. The position peaked at $5.84M in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Hancock Whitney reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 1,000 Cardlytics shares in Q3 2021, an estimated $1.27M.
  • Hancock Whitney first reported a position in Cardlytics in Q3 2019 and held it in 8 quarters.
  • Hancock Whitney's Cardlytics position peaked at $5.84M in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.